📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
87 analysed today
FollowTelegram
87
Today
151,949
All-time analysed
43,575
Positive
6,744
Negative
92,791
Neutral
8,771
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
848 announcements match the current filters (relevance ≥ 5).
$12M Corporate Guarantees for Subsidiaries and Q1 FY27 Results Announced
Triveni Turbine Limited (TTL) has approved corporate guarantees totaling $12 million (approx. ₹100 cr) to support non-fund based working capital for its Dubai and South Africa subsidiaries. The company also reported Q1 FY27 consolidated revenue of ₹442.7 cr, a 19.2% YoY increase from ₹371.3 cr. However, consolidated net profit for the quarter declined 20.6% YoY to ₹51.1 cr, down from ₹64.4 cr in the previous year's corresponding quarter. The guarantees represent approximately 8.1% of the company's net worth, facilitating international market expansion.
Confidence: HIGH
What changedThe company has extended financial backing to its international step-down subsidiaries and reported a mix of revenue growth and profit decline for the first quarter of FY27.
Why it mattersThe guarantees enable international subsidiaries to bid for and execute larger global contracts, aligning with the company's strategy to target global markets, though the Q1 profit dip warrants a closer look at operating costs.
Total Guarantee Value: $12 millionGuarantee vs Net Worth: ~8.1%Q1 FY27 Revenue Growth (YoY): 19.2%Q1 FY27 Net Profit Decline (YoY): 20.6%Consolidated EPS (Q1): ₹1.60
📅 Short termThe stock may face pressure due to the year-on-year decline in net profit, despite the growth in revenue and international expansion support.
📈 Long termStrengthening international subsidiaries is structurally positive for global market share, provided the company can stabilize margins as it scales.
⚠ Risk flags
- Contingent liability from corporate guarantees
- Margin compression in Q1 FY27
- Dependency on international subsidiary performance
Key Highlights
Approved corporate guarantees of $3 million for Dubai subsidiary and $9 million for South Africa subsidiary.
Consolidated Revenue for Q1 FY27 grew 19.2% YoY to ₹442.7 cr (₹4,427 million).
Consolidated Net Profit for Q1 FY27 decreased 20.6% YoY to ₹51.1 cr (₹511 million).
Standalone Revenue contributed ₹396.8 cr, representing nearly 90% of consolidated operations.
Total Comprehensive Income for the quarter stood at ₹59.9 cr.
👀 What to Watch
Investors should monitor the reasons behind the margin compression in Q1 despite healthy revenue growth and track the utilization of new credit lines in international subsidiaries for order execution.
Triveni Turbine Q1 Revenue Up 19% to ₹443 Cr; Board Approves $12M in Corporate Guarantees
Triveni Turbine reported a 19.2% YoY increase in consolidated revenue to ₹442.7 Cr for Q1 FY27. However, consolidated net profit declined by 20.6% to ₹51.1 Cr, down from ₹64.4 Cr in the year-ago period, indicating significant margin pressure. The Board also approved corporate guarantees totaling USD 12 million for its Dubai and South Africa subsidiaries to facilitate non-fund based working capital. Standalone Profit Before Tax (PBT) saw a sharp decline to ₹67.0 Cr from ₹89.0 Cr YoY, despite higher sales.
Confidence: HIGH
What changedThe company reported its Q1 FY27 financial results and extended financial support to its international subsidiaries through new corporate guarantees.
Why it mattersThe profit contraction in a high P/E (54.5) stock is a concern for short-term valuation. The $12M guarantee highlights the company's focus on scaling international operations in Dubai and South Africa.
Consolidated Revenue (Q1 FY27): ₹442.7 CrConsolidated PAT (Q1 FY27): ₹51.1 CrTotal Corporate Guarantees: USD 12 millionGuarantee vs Net Worth: ~8.2%YoY Revenue Growth: 19.2%YoY PAT Growth: -20.6%
📅 Short termThe stock may face downward pressure in the near term as the market reacts to the significant year-on-year decline in profitability and EPS.
📈 Long termThe structural focus on international markets (Dubai/Africa) remains intact, but the company needs to demonstrate margin recovery to sustain its premium valuation.
⚠ Risk flags
- Margin contraction (PBT fell despite higher revenue)
- Contingent liability from $12M corporate guarantees
- Increased cost of materials consumed (₹248.3 Cr vs ₹163.8 Cr standalone)
Key Highlights
Consolidated revenue increased 19.2% YoY to ₹442.7 Cr in Q1 FY27.
Consolidated Net Profit fell 20.6% YoY to ₹51.1 Cr from ₹64.4 Cr.
Approved USD 12 million in corporate guarantees for subsidiaries in Dubai ($3M) and South Africa ($9M).
Standalone Profit Before Tax (PBT) decreased to ₹67.0 Cr from ₹89.0 Cr YoY.
Consolidated EPS for the quarter dropped to ₹1.60 from ₹2.03 in Q1 FY26.
👀 What to Watch
Investors should investigate the cause of the 20% profit decline despite 19% revenue growth, likely due to higher raw material costs or a less favorable product mix. Monitor the utilization of the $12M credit lines for international order execution.
Q1 FY27 Results: Revenue up 19% to ₹443 Cr, PAT down 20.6% to ₹51 Cr; ₹100 Cr Guarantees Issued
Triveni Turbine reported a 19.2% YoY increase in consolidated total income to ₹442.7 Cr for the quarter ended June 30, 2026. However, Net Profit after tax declined by 20.6% YoY to ₹51.1 Cr, resulting in a lower EPS of ₹1.60 compared to ₹2.03 in the previous year. The Board also approved corporate guarantees totaling USD 12 million (~₹100 Cr) for its Dubai and South Africa subsidiaries to support their working capital requirements. The results indicate a significant margin contraction despite healthy top-line growth.
Confidence: HIGH
What changedThe company reported its Q1 FY27 financial results showing a disconnect between revenue growth and profitability, and increased its financial commitment to overseas subsidiaries through new corporate guarantees.
Why it mattersThe profit decline despite revenue growth suggests rising input costs or a less favorable product mix. The USD 12 million guarantee represents approximately 8% of the company's net worth, highlighting a focused but risk-bearing international expansion strategy.
Consolidated Revenue (Q1 FY27): ₹442.7 CrConsolidated PAT (Q1 FY27): ₹51.1 CrYoY Revenue Growth: 19.2%YoY PAT Growth: -20.6%Total Corporate Guarantees: USD 12 millionGuarantee vs Net Worth: ~8.1%
📅 Short termThe stock may face downward pressure in the short term as the market reacts to the significant decline in profitability and EPS despite the revenue growth.
📈 Long termLong-term prospects depend on the company's ability to restore margins through its new CO2 turbine and heat pump technologies and the successful scaling of its international aftermarket business.
⚠ Risk flags
- Margin compression
- Liability risk from USD 12 million corporate guarantees
- Potential slowdown in global capex impacting order inflows
Key Highlights
Consolidated Total Income increased 19.2% YoY to ₹442.7 Cr from ₹371.3 Cr.
Consolidated Net Profit fell 20.6% YoY to ₹51.1 Cr from ₹64.4 Cr.
Approved USD 12 million in corporate guarantees for subsidiaries in Dubai (USD 3M) and South Africa (USD 9M).
Standalone revenue from operations grew 15.1% YoY to ₹396.8 Cr.
Consolidated EPS declined to ₹1.60 from ₹2.03 in the year-ago quarter.
👀 What to Watch
Investors should monitor management commentary regarding the causes of margin compression and the execution timeline of the ₹652 Cr order book. The performance of international subsidiaries in Dubai and South Africa will be critical given the new ₹100 Cr guarantee exposure.
46% Y-o-Y Growth in July 2026 Toll Revenue to Rs 4,056 Million
IRB Infrastructure Trust (IRBIT) reported a 46% year-on-year increase in gross toll revenue for July 2026, totaling Rs 4,056 million compared to Rs 2,769 million in July 2025. The growth is significantly bolstered by three new project SPVs—Harihara Corridors, Chandibhadra Tollway, and Meerut Budaun Expressway—which were not contributing in the previous year's period. The largest asset, IRB Golconda Expressway, saw a robust 21% growth, reaching Rs 858 million for the month.
Confidence: HIGH
What changedThe Trust has successfully integrated three new tolling assets into its portfolio since January 2026, leading to a substantial jump in monthly revenue.
Why it mattersAs an InvIT, IRBIT's ability to distribute cash to unit holders depends directly on toll collections; a 46% increase in gross revenue signals improved cash flow potential.
Total Revenue (July 2026): Rs 4,056 MillionTotal Revenue (July 2025): Rs 2,769 MillionY-o-Y Growth: ~46%New Assets Contribution: Rs 839 MillionGolconda Expressway Revenue: Rs 858 Million
📅 Short termThe stock may see positive sentiment as the market reacts to the strong growth figures and the successful ramp-up of new projects.
📈 Long termThe addition of new long-term tolling assets strengthens the Trust's portfolio and supports long-term distribution stability.
⚠ Risk flags
- Traffic volatility due to seasonal factors
- Concentration risk with Golconda Expressway contributing ~21% of total revenue
Key Highlights
Total gross toll revenue rose to Rs 4,056 million in July 2026 from Rs 2,769 million in July 2025.
Three new SPVs commissioned in 2026 contributed a combined Rs 839 million to the total revenue.
IRB Golconda Expressway remains the top contributor with Rs 858 million, up from Rs 709 million Y-o-Y.
IRB Harihara Corridors, which started tolling on January 23, 2026, contributed Rs 514 million.
Meerut Budaun Expressway, the newest addition (May 17, 2026), contributed Rs 121 million.
👀 What to Watch
Investors should track the monthly stabilization of revenue from the three new SPVs and monitor if the 21% growth in the Golconda Expressway is sustained through the monsoon season.
12% YoY Growth in July 2026 Toll Revenue to ₹158.1 Cr
IRB InvIT Fund reported a 12.2% year-on-year increase in gross toll revenue for July 2026, totaling ₹158.1 crore across its 8 project SPVs. This monthly collection represents approximately 10.2% of the fund's TTM revenue of ₹1546 crore. The growth was notably supported by the IRB Hapur Moradabad Tollway, which saw revenue rise 30.4% to ₹30 crore. Investors should note that three of the eight projects were acquired in November 2025, and the comparative figures for 2025 are provided for baseline assessment.
Confidence: HIGH
What changedThe filing provides the monthly operational performance update for July 2026, showing a 12% increase in toll collections compared to the same month last year.
Why it mattersFor an InvIT, monthly toll collection is the lead indicator for cash flow health. Consistent growth in these figures is essential for maintaining the fund's yield and servicing its ₹9,361 crore debt.
July 2026 Toll Revenue: ₹158.1 CrJuly 2025 Toll Revenue: ₹140.9 CrYoY Revenue Growth: 12.2%Monthly Revenue vs TTM Revenue: ~10.2%Number of Project SPVs: 8
📅 Short termThe 12% growth is a healthy signal for the upcoming quarterly distribution, likely supporting the current stock price levels.
📈 Long termThe inclusion of newer assets with longer lives (like the November 2025 acquisitions) is successfully scaling the revenue base, though long-term DPU growth remains capped by debt repayment structures.
⚠ Risk flags
- Traffic volatility due to seasonal factors (monsoon)
- Regulatory changes in revenue remittance (FASTag/UPI direct remittance to NHAI for specific SPVs)
Key Highlights
Total gross toll revenue for July 2026 reached ₹158.1 crore (1,581 million).
Year-on-year growth of approximately 12% compared to ₹140.9 crore in July 2025.
IRB Hapur Moradabad Tollway recorded the highest growth among SPVs, increasing from ₹23 crore to ₹30 crore.
Portfolio includes 8 project SPVs, with three acquired effective November 1, 2025.
M.V.R. Infrastructure & Tollways revenue of ₹15.6 crore is now subject to direct NHAI remittance for FASTag/UPI as of June 18, 2026.
👀 What to Watch
Investors should monitor if this double-digit growth persists through the monsoon season, as it directly impacts the distributable cash flow and quarterly DPU (Distribution Per Unit).
Cantabil Q1 FY27: 13% Revenue Growth to ₹178.8 Cr; Targets ₹1,000 Cr Revenue for FY27
Cantabil Retail reported a 13% YoY revenue increase to ₹178.8 crore for Q1 FY27, supported by a 4.04% same-store sales growth (SSSG). EBITDA margins improved significantly to 33.2% from 30.8% YoY, driven by product mix and inflation corrections, despite a 30-35% minimum wage hike in Haryana impacting factory costs. Management reiterated its FY27 revenue guidance of ₹1,000 crore, which implies a ~17% growth over TTM revenue. To achieve this, the company plans to accelerate expansion by adding 28-30 new stores (55,000-60,000 sq. ft.) in Q2 FY27.
Confidence: HIGH
What changedThe company has provided a concrete roadmap to reach ₹1,000 crore revenue, shifting focus to larger store formats and digital marketing reinvention.
Why it mattersThe margin expansion to 33.2% despite wage inflation suggests strong pricing power and operational efficiency, while the aggressive Q2 expansion plan signals confidence in demand recovery.
Q1 Revenue: ₹178.8 crEBITDA Margin: 33.2%FY27 Revenue Target: ₹1,000 crTarget vs TTM Revenue: 17.3%Q2 Store Addition Target: 28-30 storesHaryana Wage Hike: 30%-35%
📅 Short termThe stock may react positively to the margin expansion and the clear growth guidance for the remainder of FY27.
📈 Long termThe company's 'Vision 2027' remains on track, focusing on Tier-II/III expansion and diversifying into women's and kids' wear to drive a 22% revenue CAGR.
⚠ Risk flags
- Minimum wage hike impact on employee costs
- Gestation period for new stores impacting short-term PAT margins
- Online sales dip due to software integration
Key Highlights
Revenue from operations grew 13% YoY to ₹178.8 crore in Q1 FY27
EBITDA margins expanded to 33.2% from 30.8% in the previous year
Management reiterated a full-year FY27 revenue target of ₹1,000 crore
Planned addition of 28-30 new stores in Q2 FY27, doubling the square footage added in Q1
Same-store sales growth (SSSG) stood at 4.04% for the quarter with a 5% annual target
👀 What to Watch
Monitor the execution of the Q2 store expansion (55k-60k sq. ft.) and the recovery in online sales, which dipped to 5% of revenue in Q1 due to software integration issues.
Biocon Shareholders Approve ₹0.50 Dividend and New 'Unity' Incentive Plan 2026
Biocon Limited held its 48th Annual General Meeting on August 06, 2026, where shareholders approved all nine resolutions. A final dividend of ₹0.50 per share (10% of face value) was ratified for FY26. Notably, the new 'Biocon Unity Long Term Incentive Plan 2026' was approved despite significant institutional pushback, with 51.1% of institutional votes cast against the primary resolution. The plan includes Performance Stock Units (PSUs) and Restricted Stock Units (RSUs) for employees of the company and its subsidiaries.
Confidence: HIGH
What changedShareholders have formally adopted the FY26 financial results and approved a new long-term employee incentive structure, replacing or augmenting previous schemes.
Why it mattersWhile the dividend is modest (0.12% yield), the high institutional opposition to the incentive plan suggests concerns regarding dilution or performance criteria, which management may need to address in future disclosures.
Final Dividend: ₹0.50 per shareInstitutional Opposition (Res 5): 51.12%Total Votes Polled (Res 1): 1,35,15,38,230Dividend Yield (at ₹426.4): 0.12%Public Institution Shares Held: 60,42,98,852
📅 Short termThe stock is likely to remain neutral as the dividend was previously recommended and the AGM results contain no major surprises beyond the institutional voting pattern.
📈 Long termThe new incentive plan aims to align management with long-term growth, though the scale of secondary acquisitions by the Trust will determine the actual impact on market liquidity and EPS dilution.
⚠ Risk flags
- Significant institutional dissent on employee incentive plans
- Potential equity dilution from new stock-based incentive schemes
Key Highlights
Approved a final dividend of ₹0.50 per equity share for the financial year ended March 31, 2026.
Resolution 5 (Incentive Plan) passed with 99.99% total favor, but faced 51.12% opposition from institutional voters (27.18 crore votes against).
Authorized the Biocon India Limited Employees Welfare Trust for secondary acquisition of shares to implement the new incentive plans.
Re-appointed Eric Vivek Mazumdar as a Director and ratified S.R. Batliboi & Associates as statutory auditors.
The 'Biocon Unity' plan encompasses PSUs, RSUs, and Management Stock Units (MSUs) under a 'Growth Accelerator' framework.
👀 What to Watch
Investors should monitor the implementation of the 'Biocon Unity' plan and its potential impact on equity dilution. The dividend payout will follow the standard timeline post-AGM approval.
BIGBLOC Q1 FY27: Revenue Up 40% to ₹79.1 Cr; Net Loss Narrows to ₹0.7 Cr
Bigbloc Construction reported a strong 40.2% YoY revenue growth to ₹79.1 Cr for Q1 FY27, driven by a 32% surge in sales volumes to 221,545 CBM. While the company remains in a net loss position of ₹0.7 Cr, this is a significant improvement from the ₹5.0 Cr loss reported in Q1 FY26. EBITDA margins expanded by 566 bps to 7.96%, reflecting better absorption of fixed costs as capacity utilization improved to 69%. The company is benefiting from recent capacity expansions at Wada and its joint venture in Kheda.
Confidence: HIGH
What changedThe company has moved from a phase of heavy capital expenditure and low utilization to a volume-led recovery phase, significantly narrowing its quarterly losses.
Why it mattersAfter reporting a net loss for FY26, the sharp improvement in EBITDA margins and volumes suggests the company is nearing an operational inflection point where its expanded capacity (1.3 million CBM) starts generating positive bottom-line results.
Revenue (Q1 FY27): ₹79.1 CrRevenue vs TTM Revenue: ~28%Sales Volume Growth: 32% YoYEBITDA Margin: 7.96%Net Debt to Equity: 1.4xTotal Capacity: 13,00,000 CBM p.a.
📅 Short termThe stock may see positive sentiment due to the strong revenue growth and margin expansion, signaling that the operational drag from recent expansions is subsiding.
📈 Long termThe long-term outlook depends on the successful penetration of the Central India market via the Madhya Pradesh plant and the adoption rate of high-margin AAC Wall Panels.
⚠ Risk flags
- Elevated Net Debt to Equity ratio of 1.4x
- Continued net losses at the consolidated level
- Sensitivity to monsoon-related construction slowdowns
Key Highlights
Revenue from operations increased 40.2% YoY to ₹79.1 Cr (₹791 Mn).
Sales volumes grew 32% YoY to 221,545 CBM, reflecting robust demand for AAC blocks.
EBITDA margins improved significantly to 7.96% from 2.30% in the same quarter last year.
Capacity utilization reached approximately 69% in Q1 FY27, up from 53% in Q1 FY26.
Net loss narrowed to ₹0.7 Cr compared to a loss of ₹5.0 Cr in Q1 FY26.
👀 What to Watch
Investors should monitor if the company can maintain utilization above 70% to achieve a full-year net profit. Key triggers include the ramp-up of the AAC Wall Panel JV and the execution timeline for the newly acquired land in Madhya Pradesh.
Q1 PAT up 61% YoY to ₹25.7 Cr; ₹135 Cr Modernization Plan Announced
Ambika Cotton Mills reported a strong Q1 FY27 with revenue growing 34.3% YoY to ₹257.92 Cr and Net Profit increasing 61.4% YoY to ₹25.70 Cr. The company announced a ₹135 Cr modernization project for Unit IV, funded entirely via internal accruals, which will increase capacity from 43,000 to 45,000 spindles while improving productivity. A shipment delay of 6,480 spindles from Germany due to the West Asia crisis was noted, with operations now expected to start in September 2026. The company maintains its debt-free status with a net worth of ₹955 Cr.
Confidence: HIGH
What changedThe company reported a significant earnings beat compared to the previous year and initiated a major ₹135 Cr modernization program for its Unit IV plant.
Why it mattersThe modernization aims to improve manufacturing efficiency and product quality, while the strong Q1 results indicate robust demand in the premium textile segment despite global supply chain headwinds.
Q1 Revenue: ₹257.92 CrQ1 Net Profit: ₹25.70 CrModernization Capex: ₹135 CrCapex vs TTM Revenue: 17.3%EPS (Q1): ₹44.89
📅 Short termThe stock is likely to react positively to the 61% profit growth and the self-funded expansion announcement.
📈 Long termModernization of existing units should help maintain the company's cost leadership and high-margin profile in the fragmented textile industry.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Supply chain disruptions (West Asia crisis) affecting equipment delivery
- Raw cotton price volatility as the company does not hedge
- Execution risk of the modernization project
Key Highlights
Revenue from operations grew 34.3% YoY to ₹257.92 Cr in Q1 FY27.
Net Profit increased 61.4% YoY to ₹25.70 Cr compared to ₹15.92 Cr in Q1 FY26.
Announced ₹135 Cr modernization of Unit IV, representing approximately 12.3% of current Market Cap.
Unit IV capacity to increase from 43,000 to 45,000 spindles with enhanced productivity and quality.
Operationalization of 6,480 spindles delayed to September 2026 due to West Asia crisis shipment issues.
👀 What to Watch
Monitor the commissioning of the 6,480 spindles in September 2026 and the execution timeline of the ₹135 Cr modernization project to see if it sustains the current margin expansion.
₹873 Cr PAT in Q1 FY27; SBI Funds Management Reports 15% Revenue Growth in First Post-IPO Call
SBI Funds Management reported a robust Q1 FY27 with operating revenue reaching ₹1,149 crores, a 15% YoY increase. The company maintained its market leadership with a 15.1% share of industry QAAUM, which stood at ₹12.6 trillion. Profit after tax grew 37% on a sequential basis to ₹873 crores, supported by stable margins and a 12% growth in unique investor count to 1.82 crores. The alternate business segment, including AIF and PMS, continues to scale, reaching a total AUM of ₹16.5 trillion.
Confidence: HIGH
What changedThis is the first earnings call following the company's listing, providing detailed operational metrics and growth strategies for the newly public entity.
Why it mattersThe results confirm the company's ability to maintain market leadership and profitability despite regulatory shifts and market volatility, leveraging its massive distribution network of 23,000+ SBI branches.
Operating Revenue: ₹1,149 crProfit After Tax (PAT): ₹873 crMF QAAUM: ₹12.6 trillionMarket Share: 15.1%Unique Investors: 1.82 crDigital Transactions: 94%
📅 Short termPositive sentiment is expected due to strong PAT growth and stable margins reported in the first post-IPO results.
📈 Long termStructural growth is supported by the ongoing financialization of Indian household savings and the company's expansion into high-margin alternate assets and international mandates.
⚠ Risk flags
- Regulatory changes regarding expense ratios
- Market volatility affecting AUM
- Competition in the passive segment
Key Highlights
Mutual Fund QAAUM grew 11% YoY to ₹12.6 trillion, maintaining a 15.1% market share.
Operating revenue increased by 15% YoY to ₹1,149 crores, while operating profit rose 17% to ₹907 crores.
Unique investor base expanded by 12% YoY to 1.82 crores as of June 30, 2026.
Monthly SIP inflows grew 14% YoY to approximately ₹4,000 crores.
Non-mutual fund AUM (PMS, AIF, offshore) reached ₹16.5 trillion, with AIF assets up 29% YoY to ₹6,800 crores.
👀 What to Watch
Investors should monitor the growth of the high-margin alternate business (AIF/PMS) and the impact of potential regulatory changes on base expense ratios.
Bigbloc Q1 Revenue Up 40% YoY to ₹79.15 Cr; Consolidated Net Loss Narrows to ₹0.82 Cr
Bigbloc Construction reported a strong 40.4% YoY growth in consolidated revenue for Q1 FY27, reaching ₹79.15 Cr compared to ₹56.36 Cr in the previous year. The company significantly narrowed its consolidated net loss to ₹0.82 Cr from a loss of ₹4.96 Cr in Q1 FY26, signaling improved operational efficiency. Consolidated capacity utilization improved to 69%, although the Siam Cement JV is currently lagging at 38%. However, the auditor issued a qualified opinion regarding the non-provisioning of employee benefits, which deviates from Ind AS 19.
Confidence: HIGH
What changedThe company has significantly increased its top-line and reduced quarterly losses compared to the previous year, driven by higher capacity utilization across its main plants.
Why it mattersThe narrowing loss and 40% revenue growth indicate that recent capacity expansions (like Wada Phase 2) are beginning to scale, though the company is yet to achieve consolidated bottom-line profitability.
Revenue (Q1 FY27): ₹79.15 CrNet Loss (Q1 FY27): ₹0.82 CrRevenue vs TTM Revenue: ~28%Consolidated Capacity Utilization: 69%JV Capacity Utilization: 38%
📅 Short termThe market is likely to view the sharp reduction in losses and strong revenue growth positively in the coming weeks.
📈 Long termLong-term sustainability depends on the Siam Cement JV reaching optimal utilization and the successful entry into the Madhya Pradesh market to optimize logistics costs.
⚠ Risk flags
- Auditor qualification on Ind AS 19 (Employee Benefits)
- High Debt-to-Equity ratio of 1.74
- Underutilization of JV capacity (38%)
Key Highlights
Consolidated revenue from operations grew 40.4% YoY to ₹79.15 Cr.
Net loss for the quarter narrowed to ₹0.82 Cr from ₹4.96 Cr in the same period last year.
Consolidated capacity utilization reached 69%, with the BBEPL subsidiary performing at 84%.
The Siam Cement Bigbloc JV reported a lower capacity utilization of 38% for the quarter.
Auditor flagged a deviation from Ind AS 19 due to non-provisioning for post-employment benefits on an accrual basis.
👀 What to Watch
Watch for the ramp-up in capacity utilization at the Siam Cement JV plant and the potential financial impact if the company aligns its employee benefit accounting with Ind AS 19.
26% Revenue Growth in Q1 FY27; API Segment Surges 42% YoY
Concord Biotech reported a strong recovery in Q1 FY27 with revenues reaching ₹257 cr, a 26.2% YoY increase compared to ₹204 cr in Q1 FY26. The growth was primarily driven by the API segment, which grew 42% YoY to ₹219 cr, and a robust 46% surge in export revenues. Management has set an ambitious long-term target to reach ₹2,200 cr in API revenue over the next 5-6 years, more than doubling its current TTM revenue of ₹1,055 cr. The company is focusing on scaling its new injectable facility and its US front-end platform, Stellon Biotech, to sustain a 25% CAGR.
Confidence: HIGH
What changedThe company has moved past the regulatory and geopolitical headwinds of FY26, showing a sharp recovery in API sales and export momentum.
Why it mattersThe strong Q1 performance validates the scalability of Concord's niche fermentation platform and its ability to maintain high margins (35% OPM) while expanding into regulated markets like the US and Brazil.
Q1 FY27 Revenue: ₹257 crAPI Revenue Growth: 42% YoYExport Revenue Growth: 46% YoYLong-term API Revenue Target: ₹2,200 crTarget vs TTM Revenue: 208%Unit 1 Capacity Utilization: 78%
📅 Short termThe stock may see positive sentiment as the 26% revenue growth signals a turnaround from the previous year's stagnation.
📈 Long termThe structural shift toward injectables and direct US distribution, combined with a target to double API revenues, suggests significant long-term value creation if execution remains on track.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- De-growth in the formulation segment during Q1
- Geopolitical risks in the Middle East affecting government contracts
- Regulatory dependency for new product launches
Key Highlights
Q1 FY27 revenue grew 26.2% YoY to ₹257 cr, recovering from a challenging FY26.
API segment revenue increased 42% YoY to ₹219 cr, while export revenues grew 46% YoY.
Management targets API revenue of ₹2,200 cr in 5-6 years, compared to the current TTM revenue of ₹1,055 cr.
Unit 1 capacity utilization is at 78%, while Unit 2 stands at 55% with room for product-mix optimization.
Received US FDA approvals for Mycophenolate Mofetil and Tofacitinib tablets during the quarter.
👀 What to Watch
Monitor the utilization levels of the new injectable facility and the revenue contribution from the US front-end platform (Stellon Biotech) in upcoming quarters. Track the execution of the 25% CAGR guidance as the company transitions from API-heavy to a more balanced API and formulation mix.
₹21,121 Cr Q1 Net Profit: SBI Reports 10.2% YoY Growth with 18.6% Credit Expansion
SBI delivered a solid Q1 FY27 with a net profit of ₹21,121 crore, representing 10.2% YoY growth and accounting for ~24.5% of its TTM PAT. Credit expansion was robust at 18.6% YoY, significantly outpacing deposit growth of 9.7%, which led to a slight dip in the CASA ratio to 39.24%. Domestic NIMs showed a healthy sequential recovery, rising 7 bps to 3.00%. Asset quality remains a key strength, with the GNPA ratio improving to 1.47% and credit costs remaining low at 0.27%.
Confidence: HIGH
What changedSBI's loan book has surpassed ₹50 trillion while simultaneously achieving a multi-year low in Gross NPA (1.47%).
Why it mattersAs India's largest bank, SBI's 18.6% credit growth indicates strong underlying economic activity, particularly in SME and Agri sectors, while maintaining superior asset quality and digital transaction dominance (98.8%).
Net Profit (Q1): ₹21,121 CrQ1 PAT vs TTM PAT: ~24.5%Gross Advances: ₹50,47,222 CrGNPA Ratio: 1.47%Domestic NIM: 3.00%Capital Adequacy (CRAR): 15.67%
📅 Short termThe sequential improvement in NIMs and continued reduction in NPAs are likely to be viewed positively by the market in the coming weeks.
📈 Long termSBI's structural shift toward digital (YONO) and its dominant market share in home loans (>27%) position it well to capture long-term credit demand, provided it manages the credit-to-deposit gap.
⚠ Risk flags
- Deposit growth (9.73%) significantly lagging credit growth (18.63%)
- Slight YoY decline in CASA ratio to 39.24%
Key Highlights
Net Profit for Q1FY27 reached ₹21,121 crore, a 10.23% increase over the previous year.
Whole Bank Advances crossed the ₹50 trillion milestone, growing 18.63% YoY.
Gross NPA ratio improved by 36 bps YoY to 1.47%, while Net NPA stands at 0.38%.
Domestic Net Interest Margin (NIM) improved to 3.00%, up 7 bps from the preceding quarter.
SME and Agri advances showed high growth at 22.33% and 25.43% YoY respectively.
👀 What to Watch
Monitor the bank's ability to accelerate deposit mobilization to support high credit growth without further compressing the CASA ratio. Watch for the sustainability of NIMs at the 3% level in a potentially changing interest rate environment.
₹21,121 Cr Q1 Net Profit; SBI reports 18.6% loan growth and multi-decade low NPA ratios
SBI reported a 10.23% YoY increase in net profit to ₹21,121 Cr for Q1FY27, supported by robust credit growth of 18.63% YoY. Asset quality reached a two-decade high with Gross NPA at 1.47% and Net NPA at 0.38%. While domestic NIM remained stable YoY at 3.00%, it showed a sequential improvement of 7 bps over Q4FY26. The bank's balance sheet expanded 13.2% YoY to ₹76.62 Lakh Cr, reflecting strong systemic credit demand.
Confidence: HIGH
What changedSBI delivered a strong start to FY27 with double-digit profit growth and significant improvement in asset quality metrics compared to the previous year.
Why it mattersAs India's largest bank, SBI's ability to maintain 18%+ credit growth while keeping credit costs at a low 0.27% indicates high operational efficiency and robust risk management.
Net Profit (Q1): ₹21,121 CrGross Advances: ₹50,47,222 CrGross NPA: 1.47%Domestic NIM: 3.00%Credit Cost: 0.27%CRAR: 15.67%
📅 Short termThe stock is likely to react positively to the sequential margin improvement and robust loan book growth reported in this presentation.
📈 Long termSBI's dominant market share and structurally improving return ratios (RoE 17.87%) position it well for long-term credit cycle participation.
⚠ Risk flags
- Rising cost of deposits (Domestic cost up to 5.21% from 4.85% YoY)
- Potential NIM compression if RBI initiates policy rate cuts
Key Highlights
Gross Advances crossed the ₹50 Trillion mark, growing 18.63% YoY led by Agri (25.43%) and SME (22.33%) segments.
Net Profit reached ₹21,121 Cr, a 10.23% increase over Q1FY26, with an RoA of 1.11%.
Gross NPA ratio improved to 1.47%, the lowest level in over two decades, while Credit Cost fell to 0.27%.
Capital Adequacy Ratio (CRAR) strengthened to 15.67%, an improvement of 104 bps YoY.
Digital adoption remains dominant with 98.8% of transactions through alternate channels and 10.5 Cr YONO users.
👀 What to Watch
Monitor the sustainability of credit growth in the RAM (Retail, Agri, MSME) segments and the impact of potential RBI rate changes on NIMs. Watch for the launch of YONO 2.0 as a driver for further digital customer acquisition.
Rs 21,121 Cr Standalone PAT: SBI reports 10.2% YoY profit growth; GNPA improves to 1.47%
State Bank of India (SBI) reported a standalone net profit of Rs 21,121.22 Cr for Q1 FY27, a 10.2% increase from Rs 19,160.44 Cr in Q1 FY26. Asset quality showed significant improvement, with the Gross NPA ratio declining to 1.47% from 1.83% YoY. Total standalone income rose to Rs 1,43,819.15 Cr, driven by interest income of Rs 1,27,896.45 Cr. The bank's capital position remains strong with a Capital Adequacy Ratio of 15.67%, up from 14.63% in the previous year.
Confidence: HIGH
What changedSBI reported its Q1 FY27 financial results, demonstrating steady double-digit profit growth and continued reduction in non-performing assets.
Why it mattersAs India's largest bank, SBI's improving asset quality (Net NPA at 0.38%) and strong capital buffers indicate a healthy credit cycle and robust internal accruals.
Standalone Net Profit: Rs 21,121.22 CrGross NPA %: 1.47%Net NPA %: 0.38%Capital Adequacy Ratio: 15.67%Interest Income: Rs 1,27,896.45 Cr
📅 Short termThe stock is likely to react positively to the improvement in asset quality and the sequential growth in operating profit.
📈 Long termSBI's massive scale and strengthening balance sheet position it as a primary beneficiary of India's long-term credit growth, particularly in SME and Home Loan segments.
⚠ Risk flags
- Potential NIM compression if deposit costs rise faster than loan yields
- Sensitivity to RBI policy rate changes
Key Highlights
Standalone Net Profit grew 10.2% YoY to Rs 21,121.22 Cr in Q1 FY27.
Gross NPA ratio improved to 1.47% from 1.83% in the year-ago period.
Net NPA ratio declined to 0.38% compared to 0.47% in June 2025.
Capital Adequacy Ratio (Basel III) strengthened to 15.67% from 14.63% YoY.
Consolidated Net Profit for the quarter stood at Rs 24,113.00 Cr, up 13.7% YoY.
👀 What to Watch
Monitor management commentary regarding Net Interest Margin (NIM) trends and the execution timeline for the YONO 2.0 digital platform launch.
IFB Industries Approves Q1 FY27 Financial Results; TTM Revenue at ₹5,531 Cr
IFB Industries has approved its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The board meeting was extensive, lasting nearly seven hours from 11:00 a.m. to 5:55 p.m. While the specific quarterly figures were not summarized in the cover letter, the company entered this period with a TTM revenue of ₹5,531 Cr and a PAT of ₹142 Cr. Investors should focus on the performance of the AC segment and the Engineering division's EV-neutral component growth.
Confidence: HIGH
What changedThe company has formally adopted and released its financial performance data for the first quarter of the 2026-27 fiscal year.
Why it mattersQ1 results are a key indicator of seasonal demand for the AC and cooling segments, which are critical for IFB's margin recovery given their high import sensitivity.
TTM Revenue: ₹5531 CrTTM PAT: ₹142 CrImport Cost Base: 60-66%Meeting Duration: 6 hours 55 minutes
📅 Short termThe stock may react based on how the Q1 FY27 PAT compares to the ₹25.36 Cr reported in Q1 FY26.
📈 Long termStructural growth depends on the successful ramp-up of the Engineering division's automotive OEM clients and the indigenization of the appliance supply chain to protect against INR depreciation.
⚠ Risk flags
- High import dependence (60-66%)
- Currency fluctuation risk
- Seasonal margin volatility
Key Highlights
Board approved unaudited financial results for the quarter ended June 30, 2026
Board meeting duration spanned approximately 6 hours and 55 minutes
TTM Revenue leading into this quarter was ₹5,531 Cr with a 5.6% operating margin
Engineering division previously reported EV-positive components representing 14% of new orders (₹19 Cr)
Company maintains a high import dependence with a 60-66% cost base
👀 What to Watch
Review the detailed segment-wise results to check if the AC segment (23% of revenue) maintained its breakeven status and if the cost-reduction program is meeting its ₹200 Cr savings target.
MobiKwik reports Q1 FY27 PAT of ₹7.6 Cr; targets ₹40 Cr full-year profit
MobiKwik achieved its third consecutive profitable quarter with a Q1 FY27 PAT of ₹7.6 Cr, representing a ₹49.5 Cr turnaround from the previous year's Q1 loss. Platform GMV reached an all-time high of ₹58,700 Cr, up 50% YoY, while direct costs were compressed by 21%. The company has set a full-year PAT target of ₹40 Cr and aims to scale quarterly lending disbursals to ₹1,000 Cr. Notably, the company holds a tax shield of ₹900-₹1,000 Cr from past losses, which will prevent immediate tax outgo.
Confidence: HIGH
What changedMobiKwik has transitioned from a loss-making entity to a consistently profitable one, with a clear ₹40 Cr PAT target for FY27.
Why it mattersThe turnaround validates the company's strategy of using high-volume payments to drive high-margin lending, while successfully decoupling revenue growth from fixed costs.
Q1 FY27 PAT: ₹7.6 CrPlatform GMV: ₹58,700 CrFull-year PAT Target: ₹40 CrAccumulated Tax Shield: ₹900 - ₹1,000 CrCash Balance: ₹437 CrShort-term Debt: ₹320.4 Cr
📅 Short termThe stock may see positive sentiment as the company confirms its turnaround is sustainable and provides specific profitability guidance for the full year.
📈 Long termStructural profitability and a massive tax shield provide a long runway; long-term success depends on scaling the lending book and potential UPI monetization.
⚠ Risk flags
- Regulatory dependency on NPCI/RBI for UPI monetization
- Cannibalization of revenue-generating wallet transactions by zero-revenue UPI
- Execution risk in scaling lending disbursals to ₹1,000 Cr per quarter
Key Highlights
Q1 FY27 PAT stood at ₹7.6 Cr, marking the third straight quarter of profitability.
Platform GMV grew 50% YoY to reach ₹58,700 Cr, the 14th consecutive quarter of growth.
Financial services gross profit grew 5.6x YoY to ₹43.3 Cr, driven by robust credit quality.
Direct costs reduced by 21% YoY, with lending-specific direct costs down 40%.
Management targeting ₹1,000 Cr quarterly lending disbursals, up from the current ₹700 Cr baseline.
👀 What to Watch
Watch for the company's ability to hit the ₹1,000 Cr quarterly lending disbursal target and any regulatory updates regarding UPI/PPI monetization which could unlock further revenue.
6-Year Forensic Audit initiated by SEBI for Nath Bio-Genes (FY21-FY26)
SEBI has appointed CNK & Associates LLP to conduct a forensic audit of Nath Bio-Genes (India) Limited, covering the period from FY 2020-21 to FY 2025-26. The audit will examine books of account and records based on specific matters identified by the regulator. With a market cap of ₹311 Cr and TTM revenue of ₹445 Cr, the company is currently trading at a low P/E of 7.5. The company has stated it is extending full cooperation to the auditors, though the specific triggers for the audit remain undisclosed.
Confidence: HIGH
What changedSEBI has formally initiated a forensic audit of the company's financial records for the past six years.
Why it mattersA forensic audit by the regulator is a high-impact event that indicates concerns regarding financial reporting or governance, which could lead to significant penalties or operational restrictions if irregularities are found.
Audit Period: FY 2020-21 to FY 2025-26Market Cap: ₹311 CrTTM Revenue: ₹445 CrP/E Ratio: 7.5
📅 Short termExpect negative sentiment and potential price volatility in the coming weeks as the market reacts to the regulatory scrutiny.
📈 Long termThe long-term outlook is highly dependent on the audit findings; adverse results could permanently damage the company's valuation and credibility.
⚠ Risk flags
- Regulatory Action
- Governance Risk
- Potential Financial Misstatement
Key Highlights
Forensic audit covers a 6-year period from FY 2020-21 to FY 2025-26
SEBI appointed CNK & Associates LLP as the Forensic Auditor via communication dated August 5, 2026
Company reports TTM revenue of ₹445 Cr and TTM PAT of ₹42 Cr as of the latest period
Audit will examine books of account and records for the specified financial years
👀 What to Watch
Investors should monitor for any subsequent disclosures regarding the findings of the forensic audit or any interim orders from SEBI; avoid reacting to speculation until findings are public.
₹167 Cr Greenfield Expansion: BirlaNu to Boost Fibre Cement Board Capacity by 54%
BirlaNu Limited has approved a ₹167 crore greenfield expansion to set up a new Fibre Cement Board plant in Hyderabad, Telangana. This project will add 72,000 MTPA to the existing 1,32,000 MTPA capacity, representing a substantial 54.5% increase in this segment. The expansion is scheduled for completion within 24 months and will be funded through internal accruals and borrowings. Alongside the expansion, the company reported a strong standalone Q1 FY27 net profit of ₹49.69 crore, up from ₹19.68 crore YoY.
Confidence: HIGH
What changedBirlaNu is initiating a major greenfield expansion to increase its Fibre Cement Board capacity by over 50%, moving from 1,32,000 MTPA to 2,04,000 MTPA.
Why it mattersThis expansion is a key step toward the company's $1 billion revenue goal, targeting premium product lines and better market accessibility in South India.
Investment Value: ₹167 croreCapacity Addition: 72,000 MTPAInvestment vs TTM Revenue: 8.1%Existing Capacity Utilization: 80%Q1 FY27 Standalone PAT: ₹49.69 croreCompletion Timeline: 24 months
📅 Short termThe stock may see positive momentum driven by the significant capacity announcement and a strong YoY recovery in standalone quarterly profits.
📈 Long termThe 54% capacity jump in Fibre Cement Boards provides a structural volume growth runway for FY28 and beyond, assuming successful execution and market absorption.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Execution risk over the 24-month project period
- Increased interest costs from new borrowings
- Regulatory sensitivity regarding asbestos-based products (31% of revenue)
Key Highlights
Proposed capacity addition of 72,000 MTPA of Fibre Cement Boards against existing 1,32,000 MTPA.
Estimated investment of ₹167 crore, which is approximately 8.1% of TTM revenue.
Project execution timeline of 24 months for the greenfield facility.
Existing capacity utilization is currently at 80% on an annualized basis.
Standalone Q1 FY27 revenue grew 10% YoY to ₹824.32 crore.
👀 What to Watch
Monitor the execution timeline of the Hyderabad plant and the impact of new borrowings on the debt-to-equity ratio. Investors should also track the progress of the Clean Coats merger currently pending before the NCLT.
Rs 167 Cr Greenfield Expansion and 152% YoY PAT Growth in Q1 FY27
BirlaNu Limited reported a strong Q1 FY27 with standalone revenue growing 10% YoY to ₹824.32 cr and Net Profit surging 152% to ₹49.69 cr. The Board approved a ₹167 cr greenfield expansion for a Fibre Cement Board plant in Hyderabad, adding 72,000 MTPA capacity. This represents a 54.5% increase over existing capacity, funded through internal accruals and debt. The company is also progressing with the merger of Clean Coats Private Limited, with NCLT hearings scheduled for August and October 2026.
Confidence: HIGH
What changedBirlaNu has committed to a major capacity expansion in its Fibre Cement segment while delivering a significant recovery in quarterly profitability compared to the previous year.
Why it mattersThe 54.5% capacity addition in Fibre Cement boards aligns with the company's $1 Billion revenue target and focuses on scaling premium product lines to improve margins.
Q1 Standalone PAT: ₹49.69 crExpansion Capex: ₹167 crCapex vs TTM Revenue: ~8.1%Proposed Capacity Addition: 72,000 MTPACapacity Increase %: 54.5%
📅 Short termThe stock is likely to react positively to the sharp YoY earnings growth and the announcement of a significant growth-oriented capex.
📈 Long termThe expansion supports long-term revenue growth and market share gains in the Fibre Cement segment, though the 24-month execution window and debt levels for financing are key variables.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Execution risk for the 24-month greenfield project
- Potential increase in debt-to-equity ratio for financing
- Regulatory risks related to asbestos-based products (31% of revenue)
Key Highlights
Standalone Net Profit increased by 152.5% YoY to ₹49.69 cr in Q1 FY27
Proposed ₹167 cr investment for a new 72,000 MTPA Fibre Cement Board plant in Hyderabad
Capacity expansion represents a 54.5% increase over the current 1,32,000 MTPA capacity
Project timeline set at 24 months, to be funded via internal accruals and borrowings
Standalone Revenue from operations grew 10% YoY to ₹824.32 cr
👀 What to Watch
Monitor the execution timeline of the Hyderabad plant over the next 24 months and the final NCLT approval for the Clean Coats merger, with the next hearing on August 13, 2026.
